tiprankstipranks
Trending News
More News >
3D Medicines, Inc. (HK:1244)
:1244
Hong Kong Market

3D Medicines, Inc. (1244) Income Statement

Compare
2 Followers

3D Medicines, Inc. Income Statement

Last quarter (Q4 2024), 3D Medicines, Inc.'s total revenue was ¥119.61M, a decrease of -15.29% from the same quarter last year. In Q4, 3D Medicines, Inc.'s net income was ¥-39.58M. See 3D Medicines, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 445.65M¥ 634.95M¥ 567.39M¥ 60.26M¥ 0.00
Gross Profit
¥ 371.74M¥ 524.01M¥ 525.18M¥ 55.98M¥ 0.00
Operating Expenses
¥ 495.17M¥ 1.01B¥ 846.54M¥ 559.07M¥ 303.93M
Depreciation and Amortization
¥ 7.86M¥ 25.46M¥ 21.60M¥ 12.59M¥ 3.37M
EBITDA
¥ -226.95M¥ -529.23M¥ -1.03B¥ -1.45B¥ -303.35M
Operating Income
¥ -123.43M¥ -497.25M¥ -996.47M¥ -1.46B¥ -627.48M
Other Income/Expenses
¥ -75.95M¥ -65.22M¥ -730.66M¥ -958.74M¥ -330.88M
Pretax Income
¥ -199.38M¥ -562.47M¥ -1.05B¥ -1.46B¥ -635.38M
Net Income
¥ -182.66M¥ -524.70M¥ -1.02B¥ -1.43B¥ -635.38M
Per Share Metrics
Basic EPS
¥ -0.75¥ -2.30¥ -22.52¥ -36.72¥ -13.93
Diluted EPS
¥ -0.75¥ -2.30¥ -22.52¥ -36.72¥ -13.93
Weighted Average Shares Outstanding
244.96M 228.47M 45.49M 39.05M 45.60M
Weighted Average Shares Outstanding (Diluted)
244.96M 228.47M 45.49M 39.05M 45.60M
Currency in CNY

3D Medicines, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis